Allergan and AstraZeneca Commit to Antibiotic Development Deal

According to Genengnews.com, “Dublin-based Allergan has entered into an agreement with AstraZeneca to develop and commercialize a fixed-dose antibiotic formulation currently in Phase II study. The financial terms of the agreement were not detailed, though...

ICYMI: FDA and Manufacturers Map Out PDUFA Reform Priorities

According to an article via BioPharmInternational.com, “A year-long process reauthorizing the Prescription Drug User Fee Act (PDUFA) was launched July 15, 2015 with a public meeting, setting the stage for monthly discussions with industry beginning this fall and...

A Look at the Top Pharma M&A Deals of 2014

    Mergers and acquisitions of biopharma companies saw a huge increase in 2014, with the largest deal more than quadrupling the top deal of 2013, and the top 10 deals all exceeding a whopping $10 billion. Take a look at the top 10 mergers and acquisitions...